GlassScriptPhysician profile
Khin Sandar Pyai
NPI 1912535006
$1,604.77
in general payments reported to CMS, 2019-2025
16 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.33 · 2023: $24.97 · 2024: $537 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $935 · Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $935.35 |
| Food and Beverage | $654.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $388.22 | 2025 | Jaypirca, Verzenio |
| Incyte Corporation | $210.69 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $184.99 | 2025 | Soliris |
| Jazz Pharmaceuticals INC. | $143.43 | 2024 | |
| Janssen Pharmaceuticals, INC | $124.99 | 2024 | Xarelto |
| Sobi, INC | $118.19 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $99.99 | 2025 | |
| Exelixis INC. | $74.99 | 2024 | |
| Beigene USA, INC. | $50.07 | 2024 | Brukinsa |
| Caris Mpi, INC. | $42.14 | 2025 | Mi Cancer Seek |
| Geron Corporation | $41.22 | 2025 | Rytelo |
| Novartis Pharmaceuticals Corporation | $36.78 | 2025 | |
| Genzyme Corporation | $29.81 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $24.97 | 2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $18.96 | 2024 | Tagrisso |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khin Pyai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.